2025 annual financial data
Actuate Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -22,495,312 USD and net income was -22,227,852 USD.
Operating cash flow was -19,206,253 USD.
Get free Actuate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,495,312 USD
- Net income
- -22,227,852 USD
- Operating cash flow
- -19,206,253 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Actuate Therapeutics financial years